Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1996-02-16
1999-01-26
Dees, Jose G.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
424 93, A61B 5055
Patent
active
058635190
ABSTRACT:
There is provided a contrast medium composition comprising: (a) a first contrast agent comprising a physiologically tolerable manganese compound together with an uptake promoter, having a manganese concentration of at least 0.3 mM or being in a dosage unit form containing at least 300 .mu.mol manganese, wherein the uptake promoter comprises a physiologically tolerable reducing compound containing an .alpha.-hydroxy ketone group or a physiologically tolerable acid containing .alpha.- and/or .beta.- hydroxy or amino groups, or a salt thereof, and/or vitamin D; together with (b) a second contrast agent.
Such compositions are particularly suitable for imaging of the liver.
REFERENCES:
patent: 4804529 (1989-02-01), Bardy et al.
patent: 4826673 (1989-05-01), Dean et al.
patent: 4859451 (1989-08-01), Quay et al.
patent: 4963344 (1990-10-01), Gries et al.
patent: 5128121 (1992-07-01), Berg et al.
patent: 5143716 (1992-09-01), Unger
patent: 5250285 (1993-10-01), Lauffer et al.
patent: 5290537 (1994-03-01), Moore et al.
patent: 5292729 (1994-03-01), Ashmead
patent: 5314680 (1994-05-01), Rajagopalan et al.
patent: 5314681 (1994-05-01), Leunbach et al.
patent: 5439668 (1995-08-01), Almen et al.
Johnson et al., Proc. Soc. Exp. Biol. Med., 199(4), 470-480, 1992.
Seaborn et al., Biol. Trace Elem. Res., 41(3), 279-294, Jun. 1994.
Bell et al., J. Toxicol. Environ. Health, 26(4), 387-398, 1989.
Giurgea et al., Stud. Cercet. Biol. Ser. Biol. Anim., 44(2), 135-137, 1992.
Lonnerdal, J. Nutr., 119(12), 1839-1844; discussion 1845, 1989.
Gerard et al., Bull. Soc. Chim. Fr., No. 11-12, Pt. 1, 2404-2408, 1975.
Gerard, Bull. Soc. Chim. Fr., No. 11-12, 451-456, 1979.
Rubin et al., Magn. Reson. Med., 23(1), 154-165, 1992.
Stampfli et al., J. Coord. Chem., 1(3), 173-177, 1972.
Petrola, Finn. Chem. Lett., 13(5), 129-135, 1986.
Berg Arne
Golman Klaes
Gunther Wolfgang
Klaveness Jo
Leander Peter
Dees Jos,e G.
Hartley Michael G.
Nycomed Imaging AS
LandOfFree
Composition and method of MRI using both a positive and a negati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method of MRI using both a positive and a negati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method of MRI using both a positive and a negati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1447883